CLINICAL Endocrinology
Volume 50, Number 1, January 1999




Contents

Review

1 Cardiovascular disease and risk factors in adults with
hypopituitarism: s. A. BESHYAH AND D. G. JOHNSTON


Commentary

17 Y-chromosomemosaicism in girls with Turner's syndrome:
c. CHU (see page 19)


Original papers

19 Y-chromosome identification by PCR and gonadal histopathology
m Turner's syndrome without overt Y-mosaicism: J. R. T. MENDES,
M. W. L. STRUFALDI, R. DELCELO, R. C. M. S. MOISTS, J. G. VIEIRA,
T. S. KASAMATSU, M. F. GALERA, J. A. D. ANDRADE AND
i. T. N. VERRESCHI (see commentary page 17)



27 Recent primary transnasal surgical outcomes associated with
intraoperative growth hormone measurement in acromegaly:
T. ABE AND D. K. LÜDECKE



37 The effects of interleukin-2 treatment on endothelin and the
activation of the hypothalamic-pituitary-adrenal axis: c. RAAB,
E. WEIDMANN, A. SCHMIDT, L. BERGMANN, K. BADENHOOP,
K. H. USADEL AND T. HAAK



45 A low individualized GH dose in young patients with childhood
onset GH deficiency normalized serum IGF-I without significant
deterioration in glucose tolerance: B. BÜLOW AND E. M. ERFURTH



57 Experience with transdermal testosterone replacement therapy
for hypogonadal men: s. PARKER AND M. ARMITAGE


63 An in vivo study of the cortisol-cortisone shuttle in subcutaneous
abdominal adipose tissue: J. R. KATZ, v. MOHAMED-ALI, p. J. WOOD,
J. S. YÜDKIN AND S. W. COPPACK



69 Novel DAX I m,utations in X-linked adrenal hypoplasia congenita
and hypogonadotrophic hypogonadism: J. H. D. BASSETT,
D. J. O,HALLORAN, G. R. WILLIAMS, C. G. BEARDWELL, S. M. SHALET
AND R. V. THAKKER



77 The effect of chronic hexarelin administration on the
pituitary-adrenal axis and prolactin: A. RAHIM, P. A. O'NEIL AND
S. M. SHALET



85 High precursor level in maternal blood results from the alternate
mode of proopiomelanocortin processing in human placenta:
M. L. RAFFTN-SANSON, J. F. MASSIAS, A. ANKOTCHE, J. COSTE,
Y. DE. KEYSER, C. OLIVER, C. DUMONT, D. CABROL, F. FERRE AND
X. BERTAGNA


95 Recombinant interferon (x (rlFN-(x) does not potentiate the
effect of iodine excess on the development of thyroid
abnormalities in patients with HCV chronic active hepatitis:
R. MINELLI, L. E. BRAVERMAN, M. A. VALLI, C. SCHIANCHI,
M. PEDRAZZONI, F. FIACCADORI, M. SALVI, M. G. MAGOTTI AND
E. ROTI



101 Serum vascular endothelial growth factor (VEGF) in the normal
menstrual cycle: association with changes in ovarian and uterine
Doppier blood flow: R. AGRAWAL, G. s. CONWAY, P. SLADKEVICIUS,
N. N. PAYNE, J. BEKIR, S. CAMPBELL, S. L. TAN AND H. S. JACOBS


107 Urocortin expression in the human central nervous system:
K. UNO, H. SASANO, Y. OKI, N. ANDOH, R. W. SHIN, T. KITAMOTO,
K. TAKAHASHI, H. SUZUKI, F. TEUKA, T. YOSHIMI AND H. NAGURA



115 Addison's disease in Africa - a teaching hospital experience:
s. SOULE



121 Laparoscopic adrenalectomy for phaeochromocytoma:
endocrinological and surgical aspects of a new therapeutic
approach: v. COL, L. DE CANNIERE, E. COLLARD, L. MICHEL
AND J. DONCKIER



127 Antithyroid drugs and Graves' disease - prospective randomized
assessment of long-term treatment: D. MAUGENDRE, A. GATEL,
L. CAMPION, C. MASSART, 1. GUILHEM, Y. LORCY, J. LESCOUARCH,
J. Y. HERRY AND H. ALLANNIC



Case report

133 Rosai-Dorfman disease presenting as a pituitary tumour:
W. F. KELLY, N. BRADEY AND D. SCOONES


139 Book reviews
Author's Declaration

_____________________________________________

Clinical Endocrinology

Vol.50, NO.2, February 1999

Contents

Review
141 Investigation protocol: adrenal enlargement: F. MANTERO AND

G. ARNALDI

Commentary
147 Thyroid hormones and neurodevelopment: J. H. LAZARUS

(see page 149)

Original papers

149 Low maternal free thyroxine concentrations during early
pregnancy are associated with impaired psychomotor development
in infancy: v. J. POP, J. L. KUIJPENS, A. L. VAN BAAR, G. VERKERK,
M. M. VAN SON, J. J. DE VIJLDER, T. VULSMA, W. M. WIERSINGA,
H. A. DREXHAGE AND H. L. VADER (see commentary page 147)

157 An atypical contiguous gene syndrome: molecular studies in a
family with X-linked Kallmann's syndrome and X-linked
ichthyosis: G. MAYA-NUNEZ, L. TORRES, A. ULLOA-AGUIRRE,
J. C. ZENTENO, S. CUEVAS-COVARRUBIAS, D. SAAVEDRA-ONTIVEROS,
S. KOFMAN-ALFARO AND J. P. MENDEZ

163 Hyperleptinaemia in young adults following cranial irradiation
in childhood: growth hormone deficiency or leptin
insensitivity?: B. M. D. BRENNAN, A. RAHIM, w. F. BLUM,
J. A. ADAMS, 0. B. EDEN AND S. M. SHALET

171 Bone turnover and cortical bone mineral density in the distal
radius in patients with hyperthyroidism being treated with anti-
thyroid drugs for various periods of time: M. OIKAWA, K. KUSHIDA,
M. TAKAHASHI, T. OHISHI, H. HOSHINO, M. SUZUKI, H. OGIHARA,
J. ISHIGAKI AND T. INOUE

177 Cord blood leptin concentrations in relation to intrauterine
growth: A. VARVARIGOU, C. S. MANTZOROS AND N. G. BERATIS

185 Comparison of serum thyrotrophin concentrations determined
by a third generation assay in patients with various types of overt
and subclinical thyrotoxicosis: K. KASAGI, T. KOUSAKA, T. MISAKI,
M. IWATA, M. S. ALAM AND J. KONISHI

191 Genetic studies of a family with hereditary hyperparathyroidism-
jaw tumour syndrome: w. s. WASSIF, F. FARNEBO, B. T. TEH,
C. F. MONIZ, F. Y. LI, J. D. HARRISON, T. J. PETERS, C. LARSSON
AND P. HARRIS

197 Long-term effect of radioactive iodine on thyroid function and
size in patients with solitary autonomously functioning toxic
thyroid nodules: B. NYGAARD, L. HEGEDUS, K. G. NIELSEN,
P. ULRIKSEN AND J. M. HANSEN

203 Serum prostate specific antigen, sex hormone binding globulin
and free androgen index as markers of pubertal development in
boys: M. R. KIM, M. K. GUPTA, S. H. TRAVERS, D. G. ROGERS,
F. VAN LENTE AND C. FAIMAN

211 Serum leptin levels in women throughout pregnancy and the
postpartum period and in women suffering spontaneous
abortion: M. LAGE, R. c. GARCIA-MAYOR, M. A. TOME, F. CORDIDO,
F. VALLE-INCLAN, R. V. CONSIDINE, J. F. CARO, C. DIEGUEZ AND
F. F. CASANUEVA

217 The prevalence of subclinical hypothyroidism at different total
plasma cholesterol levels in middle aged men and women: a
need for case-finding?: A. J. G. H. BINDELS, R. G. J. \VESTENDORP,
M. FROLICH, J. C. SEIDELL, A. BLOKSTRA AND A. H. M. SMELT

221 InInsulin-like growth factor binding protein-1 in NIDDM:
relationship with the insulin resistance syndrome:
V. MOHAMED-ALI, J. H. PINKNEY, A. PANAHLOO,
S. CWYFAN-HUGHES, J. M. P. HOLLY AND J. S. YUDKIN

229 Functional hypothalamic amenorrhoea: a partial and reversible
gonadotrophin deficiency of nutritional origin: B. COUZINET,
J. YOUNG, S. BRAILLY, Y. LE BOUC, P. CHANSON AND G. SCHAISON

237 Bone mineral density and markers of bone turnover in young
adult survivors of childhood lymphoblastic leukaemia:
J. J. G. HOORWEG-NUMAN, G. KARDOS, J. C. ROOS, H. J. VAN DIJK,
C. NETELENBOS, C. POPP-SNIJDERS, C. M. DE RIDDER AND
H. A. DELEMARRE-VAN DE WAAL

245 Comparison of monthly intramuscular injections of Sandostatin
LAR with multiple subcutaneous injections of octreotide in the
treatment of acromegaly; effects on growth hormone and other
markers of growth hormone secretion: s. J. HUNTER,
J. A. M. SHAW, K. 0. LEE, P. J. WOOD, A. B. ATKINSON AND
J. S. BEVAN

253 Plasma oestrone-fatty acid ester levels are correlated with body
fat mass in humans: J. M. FERNANDEZ-REAL, D. SANCHIS,
W. RICART, R. CASAMITJANA, F. BALADA, X. REMESAR AND
M. ALEMANY

261 A comparison of the naxioxone test with the insulin stress test
in patients following transsphenoidal surgery: A. s. MCALLISTER,
D. R. MCCANCE, D. R. HADDEN, P. M. BELL, H. LESLIE, B. SHERIDAN
AND A. B. ATKINSON

Case report

267 Apparent cure of Graves-Basedow disease after sibling allogeneic
bone marrow transplantation: s. DIEZ, H. BANIAS,
J. L. DI'EZ-MARTIN, M. BRIZ, J. ESTRADA AND B. BARCELO

271 Letters to the Editors
273 Book reviews

______________________________________________

Clinical Endocrinology
Vol.50, NO. 3, March 1999

Contents

Review

275 Congenital growth hormone insensilivity syndromes and their
relevance to idiopathic short stature: p. E. CLAYTON, J. s. FREETH
AND M. R. NORMAN

285 Investigation protocol: Acromegaly and its investigation:
E. DUNCAN AND J. A. H. WASS

Original papers

295 Clinical and biochemical response following withdrawal of a
long-acting, depot injection form of octreotide (Sandostatin-
LAR®): P. M. STEWART, S. E. STEWART, P. M. S. CLARK AND
M. C. SHEPPARD

301 Peak and trough growth hormone (GH) concentrations influence
growth and serum insulin like growth factor-1 (IGF-I)
concentrations in short children: J. c. ACHERMANN,
C. G. D. BROOK, 1. C. A. F. ROBINSON, D. R. MATTHEWS AND
P. C. HINDMARSH

309 Multiple endocrine neoplasia type I (MEN 1): clinical
heterogeneity in a large family with a nonsense mutation in the
MEN I gene (Trp471 Stop): N. VALDES,
G. PEREZ DE NANCLARES, V. ALVAREZ, L. CASTANO,
F. DfAZ-CADORNIGA, J. ALLER AND E. GOTO

315 Life expectancy following surgery for pituitary tumours:
A. S. BATES, B. BULLIVANT, M. C. SHEPPARD AND P. M. STEWART

321 Left ventricular hypertrophy in primly hyperparathyroidism.
Effects of successful parathyroidectomy: A. PIOVESAN,
N. MOLINERI, F. CASASSO, 1. EMMOLO, G. UGLIENGO, F. CESARIO
AND G. BORRETTA

329 Dose response with fluticasone propionate on adrenocortical
activity and recovery of basal and stimulated responses after
vstopping treatment: A. M. WILSON, E. J. SIMS AND B. J. LIPWORTH

337 Rapid leptin decrease in immediate post-exercise recovery:
M. DUCLOS, J. B. CORCUFF, A. RUFFIE, P. ROGER AND G. MANIER

343 No overrepresentation of congenital adrenal hyperplasia in
patients with adrenocortical tumours: M. KJELLMAN, M. HOLST,
M. BACKDAHL, C. LARSSON, L. 0. FARNEBO AND A. WEDELL

347 High prevalence of osteoporosis in cardiac transplant recipients
and discordance between biochemical turnover markers and
bone histomorphometry: p. GLENDENNING, G. N. KENT,
B. D. ADLER, L. MATZ, 1. WATSON, G. J. O'DRISCOLL AND
D. M. HURLEY

357 Diagnosis and treatment of the solitary thyroid nodule. Results
of a European survey: F. N. BENNEDB^EK, H. PERRILD AND
L. HEGEDUS

365 Detection of thyroid stimulating (TSAB)- and thyrotropin
stimulation blocking (TSBAB) antibodies with CHO cell lines
expressing different TSH-receptor numbers: H. WALLASCHOFSKI
AND R. PASCHKE

373 Octreotide-scintigraphy is a disease-activity parameter in Graves'
ophthalmopathy: M. N. GERDING, F. M. VAN DER ZANT,
E. A. VAN ROYEN, L. KOORNNEEF, E. P. KRENNING, W. M. WIERSINGA
AND M. F. PRUMMEL

381 Inhibin forms in serum from postmenopausal women with
ovarian cancers: D. M. ROBERTSON, N. CAHIR, H. G. BURGER,
P. MAMERS AND N. GROOME

387 Oestrogen has no short-term effect on intestinal strontium
absorption in healthy postmenopausal women: M. TEN BOLSCHER,
G. W. DE VALK-DE ROO, R. BARTO, W. J. F. VAN DER VIJGH AND
J. COEN NETELENBOS

393 Do some men with acne vulgaris have raised levels ofLH?:
A. FARRELL, J. ALAGHBAND-ZADEH, G. CARTER, R. B. NEWSON
AND J. J. CREAM

Case report

399 Relapsing Whipple's disease presenting with hypopituitarism:
M. BRANDLE, P. AMMANN, G. A. SPINAS, F. DUTLY, R. L. GALEAZZI,
C. SCHMID AND M. ALTWEGG

405 Letters to the Editors

409 Book reviews

410 Notices
Author's Declaration

________________________________________

Clinical Endocrinology
Vol. 50, NO. 4, April 1999

Contents

Review

411 The effects of testosterone on osteoporosis in men: R. M. FRANCIS

Commentary
415 The growth hormone IGF-I axis in dilated cardiomyopathy:
R. C. JENKINS AND R. J. M. ROSS (See page 417)

Original papers
417 Activity of GH/IGF-I axis in patients with dilated cardio-
myopathy: F. BROGLIO, A. FUBINI, M. MORELLO, E. ARVAT,
G. AIMARETTI, L. GIANOTTI, M. F. BOGHEN, R. DEGHENGHI,
L. MANGIARDI AND E. GHIGO (see commentary page 415)

431 Prevalence, predictors and patterns of postoperative polyuria
and hyponatraemia in the immediate course after transsphenoidal
surgery for pituitary adenomas: J. HENSEN, A. HENIG,
R. FAHLBUSCH, M. MEYER, M. BOEHNERT AND M. BUCHFELDER

441 Evaluation of free insulin-like growth factor-I measurement on
the diagnosis and follow-up treatment of growth homone-deficient
adult patients: N. R. c. MUSOUNO, M. B. DA CUNHA NETO,
R. MARINO, D. GIANNELLA-NETO AND M. D. BRONSTEIN

451 Discrepancy between serum leptin values and total body fat in
response to the oral growth hormone sdcretagogue MK-677:
J. SVENSSON, B. CARLSSON, L. M. S. CARLSSON, J. 0. JANSSON AND
B. A. BENGTSSON

457 Endothelial dysfunction in hypopituitary adults with growth
hormone deficiency: L. M. EVANS, J. s. DAVIES, J. GOODFELLOW,
J. A. E. REES AND M. F. SCANLON

465 Evaluation of adrenal function in patients with hypothalamic
and pituitary disorders: comparison of serum cortisol, urinary
free cortisol and the human-corticotrophin releasing hormone
test with the insulin tolerance test: R. p. F. DULLAART,
S. H. PASTERKAMP, J. A. M. BEENTJES AND W. J. SLUITER

473 Circadian variation of plasma cortisol in prepubertal children
with normal stature, short stature and growth hormone
deficiency: R. c. HERMIDA, L. GARcfA, D. E. AYALA AND
J. R. FERNANDEZ

481 Kallmann's syndrome: is it always for life?: R. QUINTON,
H. K. CHEOW, D. J. TYMMS, P. M. G. BOULOUX, F. C. W. WU AND
H. S. JACOBS

487 Effect of acute high dose dobutamine administration on serum
thyrotrophin (TSH): E. LEE, p. CHEN, H. RAO, J. LEE AND
L. A. BURMEISTER

493 The HLA-DQ association with Graves' disease in Chinese
children: G. w. K. WONG, s. H. CHENG AND J. s. DORMAN

497 Cardiac function at rest in hypothyroidism evaluated by
equilibrium radionuclide angiography: E. T. TIELENS, M. PILLAY,
C. STORM AND A. BERGHOUT

503 Prevalence and significance of thyroid autoantibodies in patients
with chronic hepatitis C virus infection: a prospective controlled
Study: M. J. HUANG, S. L. TSAI, B. Y. HUANG, 1. S. SHEEN,
C. T. YEH AND Y. F. LIAW

511 Female sex hormone replacement therapy increases serum free
1,25-dihydroxyvitamin Dy a I year prospective study:
H. J. C. VAN HOOF, M. J. VAN DER MOOREN, L. M. J. W. SWINKELS,
C. G. J. SWEEP, J. M. W. M. MERKUS AND T. J. BENRAAD

517 The natural history of the metabolic syndrome in young women
with the polycystic ovary syndrome and the effect of long-term
oestrogen-progestagen treatment: R. PASQUALI, A. GAMBINERI,
B. ANCONETANI, V. VICENNATI, D. COLITTA, E. CARAMELLI,
F. CASIMIRRI AND A. M. MORSELLI-LABATE

529 Prevalence of Ras mutatons in thyroid neoplasia: C.T. ESAPA,
S. J. JOHNSON, P. KENDALL-TAYLOR, T. W. J. LENNARD AND
P. E. HARRIS

Case report

537 An adult patient with severe hypercalcaemia and hypocalciuria
due to a novel homozygous inactivating mutation of the calcium-
sensing receptor: N. CHIKATSU, s. FUKUMOTO, M. SUZAWA,
Y. TANAKA, Y. TAKEUCHI, S. TAKEDA, Y. TAMURA, T. MATSUMOTO
AND T. FUJITA

545 Letters to the Editors
Author's Declaration

_______________________________________


Clinical Endocrinology
Vol. 50, NO. 5, May 1999

Contents

Review

547 Can GHRH or GH secretagoges re-initiate pituitary GH
pulsatility?: s. CHAPPEL

Commentary

557 How many surgeons to operate on acromegalic patients:
R.N. CLAYTON (see page 561)

Original papers

561 Outcome of transphenoidal surgery for acromegaly and its
relationship to surgical experience: s. AHMED,
M. ELSHEIKH, 1. M. STRATTON, R.C.L. PAGE, C.B.T. ADAMS
AND J.A.H. WASS (see commentary page 557)

569 Insulin regulation of leptin synthesis and secretion in
humans: the model ofmyotonic dystrophy: J.M. GOMEZ,
A. MOLINA, M. FERNANDEZ-CASTANER, R. CASAMITJANA,
J.A. MARTI'NEZ-MATOS AND J. SOLER

577 A trial of growth hormone therapy in well-controlled
hypophosphataemic rickets: F.J. CAMERON, E.B. SOCHETT,
A. DANEMAN AND S.W. KOOH

583 Parathyroid hormone gene polymorphisms in primary
hyperparathyroidism: M. KANZAWA, T. SUGIMOTO,
T. KOBAYASHI. A. KOBAYASHI AND K. CHIHARA

589 Familial non-medullary thyroid carcinoma: pathology
review in 27 affected cases from 13 French families:
F. LEPRAT, F. BONICHON, M. GUYOT, H. TROUETTE,
M. TROJANI, V. VERGNOT, M. LONGY, G. BELLEANNEE.
A. DE MASCAREL AND P. ROGER

595 Relationships between dehydroepiandrosterone-sulphate
and anthropometric, metabolic and hormonal variables in
a large cohort of obese women: M. MACCARIO, E. MAZZA,
J. RAMUNNI, S.E. OLEANDRI, P. SAVIO, S. GROTTOLI,
R. ROSSETTO, M. PROCOPIO, C. GAUNA AND E. GHIGO

601 Circulating levels of human insulin-like growth factor
binding protein-6 (IGFBP-6) in health and disease as
determined by radioimmunoassay: J. VAN DOORN,
A.M. RINGELING, S.S. SHMUELI, M.C. KUIJPERS,
A.C.S. HOKKEN-KOELEGA, S.C. VAN BUUL-OFFERS AND
M. JANSEN

611 Relationship between serum and urinary insulin-like
growth factor-I through childhood and adolescence: their
use in the assessment of disordered growth: C.M. HALL,
M.S. GILL, P. FOSTER. L. PENNELLS, V. TILLMANN,
J. JONES. D.A. PRICE AND P.E. CLAYTON

619 Acidic isoforms of chorionic gonadotropin in European
and Samoan women are associated with hyperemesis
gravidarum and may be thyrotrophic: v. JORDAN,
S.K.G. GREBE, R.R. COOKE. H.C. FORD, P.D. LARSEN,
P.R. STONE AND C.E. SALMOND

629 Long-term substitution therapy of hypogonadal men with
transscrotal testosterone over 710 years: H.M. BE H RE,
S. VON ECKARDSTEIN, S. KLIESCH AND E. NIESCHLAG

637 Expression of the androgen metabolizing enzyme
UGT2B15 in adipose tissue and relative expression
measurement using a competitive RT-PCR method:
A. TCHERNOF, E. LEVESQUE, M. BEAULIEU, P. COUTOURE,
J.P. DESPRES, D.W. HUM AND A. BELANGER

643 Differentiated thyroid cancer: a retrospective analysis of
832 cases from Greece: i. TZAVARA, B. VLASSOPOULOU,
C. ALEVIZAKI, G. KOUKOULIS, M. TZANELA,
P. KOUMOUSSI, F. SOTSIOU AND N. THALASSINOS

655 Disturbances of menstruation in hypothyroidism:
G.E. KRASSAS, N. PONTIKIDES, T. KALTSAS,
P. PAPADOPOULOU, J. PAUNKOVIC, N. PAUNKOVIC AND
L. H. DUNTAS

661 Adrenal and gonadal contributions to urinary excretion
and plasma concentration of epitestosterone in men effect
of adrenal stimulation and implications for detection of
testosterone abuse: A. T. KICMAN. S.B. COUTTS,
D.A. COWAN, D.J. HANDELSMAN, C.J. HOWE, S. BURRING
AND F.C.W. WIJ

669 Amniotic fluid levels of dimeric inhibins, pro-aC inhibin,
activin A and follistatin in Down's syndrome:
E.M. WALLACE, D. D'ANTONA, C. SHEARING. L.W. EVANS,
P. THIRUNAVUKARASU, J.P. ASHBY, M. SHADE AND
N.P. GROOME

Case report

675 Gushing's syndrome secondary to ectopic ACTH secretion
from metastatic breast carcinoma: S.J. WIGG, A.R. EHRLICH
AND P.J. FULLER

679 Letters to the Editors

682 Notices
Author's Declaration

_______________________________________

Clinical Endocrinology
Vol. 50, NO. 6, June. 1999,

Contents

Review
683 Growth hormone and exercise: p. J. JENKINS

Commentary

691 Casting new light on the clinical spectrum of neonatal severe
hyperparathyroidism: s. PEARCE AND B. STEINMANN (see Clinical
Endocrinology, 50,537-543)

original papers

695 Inhibin B levels in azoospermic subjects with cytologically
characterized testicular pathology: c. FORESTA, A. BETTELLA,
F. PETRAGLIA, M. PISTORELLO, S. LUISI AND M. ROSSATO

703 GH replacement in 1034 growth hormone deficient hypopituitary
adults: demographic and clinical characteristics, dosing and
safety: R. ABS, B. A. BENGTSSON, E. H. HERNBERG-STAHL,
J. P. MONSON, J. P. TAUBER, P. WILTON AND C. WUSTER

715 Correlation between urinary cortisol and 6-sulphatoxymelatonin
rhythms in field studies of blind subjects: D. J. SKENE,
S. W. LOCKLEY, K. JAMES AND J. ARENDT

721 Constitutional delay in growth and puberty (CDGP) is associated
with hypoleptinaemia: M. s. GILL, c. M. HALL, v. TILLMANN AND
P. E. CLAYTON

727 Increased MEN I mRNA expression in sporadic pituitary tumours:
C. J. MCCABE, N. J. L. GITTOES, M. C. SHpPPARD AND J. A. FRANKLYN

735 Reduced fetal growth and growth hormone secretion in adult
life: D. E. FLANAGAN, V. M. MOORE, 1. F. GODSLAND,
R. A. COCKINGTON, J. S. ROBINSON AND D. 1. W. PHILLIPS

741 Hypothalamic derangement in traumatized patients: growth
hormone (GH) and prolactin response to thyrotrophin-releasing
hormone and GH-releasing hormone: L. DE MARINIS, A. MANCINI,
D. VALLE, A. BIANCHI, R. GENTILELLA, 1. LIBERALE, V. MIGNANI,
M. PENNISI AND F. DELLA CORTE

749 Dose titration and patient selection increases the efficacy of GH
replacement in severely GH deficient adults: R. D. MURRAY,
C. J. SKILLICORN, S. J. HOWELL, C. A. LISSETT, A. RAHIM AND
S. M. SHALET

759 The influence of hydrocortisone substitution on the quality of
life and parameters of bone metabolism in patients with secondary
hypocortisolism: M. WICHERS, w. SPRINGER, F. BIDLINGMAIER
AND D. KLINGMULLER

767 Correlation between cortisol and insulin-like growth factor-
binding proteins (IGFBPs) under physiological conditions in
children: c. E. MARTINELLI, M. E. YATEMAN, A. M. COTTERILL,
A. C. MOREIRA AND C. CAMACHO-HIJBNER

775 The impact of gender, puberty and body mass on reference
values for urinary growth hormone (GH) excretion in normally
growing non-obese and obese children: G. BONA, A. PETRI,
A. RAPA, A. CONTI AND A. SARTORIO

783 Determinants of longterm outcome of radioiodine therapy for
sporadic nontoxic goitre: R. LE MOLl, M. F. T. WESCHE,
M. M. C. TIEL-VAN BUUL AND W. M. WIERSINGA

791 Reduced androgen levels in adult Turner syndrome: influence
of female sex sleroids and growth hormone status: c. H. GRAVHOLT,
B. SVENSTRUP, P. BENNETT AND J. S. CHRISTIANSEN

801 Different immunohistochemical patterns ofTGF-pl expression
in benign and malignant adrenocortical tumours: A. BOCCUZZI,
M. TERZOLO, S. CAPPIA, P. DE GlULI, C. DE RISI, E. LEONARDO,
S. BOVIO, M. BORRIERO, P. PACCOTTI AND A. ANGELI

Case report

809 Fetal pituitary negative feedback at early gestational age:
Y. RAKOVER, E. WEINER, N. MOSH AND E. SHALEV

815 Letters to the Editors

821 Book reviews

823 Referees

825 Author index

835 Subject index

Author's Declaration

______________________________________

Clinical Endocrinology
Volume 51, Number 1, July 1999

Contents

Review
1 Apoptosis in neuroendocrine tumours: D. G. WANG

Commentary
11 Practice guidelines for the detection and management of thyroid
dysfunction. A comparative review of the recommendations:
J. E. ARBELLE AND A. PORAIH

19 Mapping of a novel tumour suppressor gene with a role in
neuroendocrine tumours: s. H. s. PEARCE (see page 27)

Rapid communication
21 Growth hormone replacement therapy in adults with growth
hormone deficiency improves vascular reactivity: E. R. CHRIST,
P. J. CHOWIENCZYK, P. H. SÖNKSEN AND D. L. RUSSEL-JONES

Original papers
27 Frequent loss of heterozygosity at chromosome 3pl4-2-3p21
in human pancreatic islet cell tumours: M. N. NIKIFOROVA,
Y. E. NIKIFOROV, P. BIDDINGER, D. R. GNEPP, L. A. GROSEMBACHER,
B. L. WAJCHENBERG, J. A. FAGIN AND R. M. COHEN (see commentary
page 19)

35 Evaluation of bone metabolism after the use of an inhaled
glucocorticoid (flunisolide) in patients with moderate asthma:
O. M. HAUACHE, E. C. J. AMARANTE, J. G. H. VIEIRA,
S. M. FARESIN, A. L. G. FERNANDES, J. R. JARDIM AND
M. LAZARETTI-CASTRO

41 Short-term leptin infusion does not affect circulating levels of
LH, testosterone or cortisol in food-restricted pubertal male
rhesus macaques: J. LADO-ABEAL, Y. o. LUKYANENKO, s. SWAMY,
R. C. HERMIDA, J. C. HUTSON AND R. L. NORMAN

53 Effects of growth hormone replacement on physical performance
and body composition in GH deficient adults:
J. RODRfGUEZ-ARNAO, A. JABBAR, K. FULCHER, G. M. BESSER
AND R. J. M. ROSS

61 Growth hormone status following treatment for Cushing's
syndrome: N. R. HUGHES, c. A. LISSETT AND s. M. SHALET

67 Salivary cortisol for screening of Cushing's syndrome in
children: c. E. MARTINELLI, s. L. SADER, E. B. OLIVEIRA,
J. C. DANELUZZI AND A. C. MOREIRA

73 Differences in the levels of TSH-binding inhibitor immuno-
globulins in goitrous and agoitrous autoimmune thyroiditis after
twelve months ofL-thyroxine therapy: D. H. c. KHOO,
P. H. K. ENG, S. C. HO AND A. C. K. FOK

81 Serum leptin levels in healthy ageing men: are decreased serum
testosterone and increased adiposity in elderly men the
consequence of leptin deficiency?: J. K. VAN DEN SAFFELE,
S. GOEMAERE, D. DE BACQUER AND J. M. KAUFMAN

89 Reduced human growth hormone (hGH) bioactivity without a
defect of the GH-1 gene in three patients with rhGH responsive
growth failure: G. BINDER, M. R. BENZ, M. ELMLINGER,
C. D. PFLAUM, C. J. STRASBURGER AND M. B. RANKE

97 Mutation screening and isoform prevalence of the follicle
stimulating hormone receptor gene in women with premature
ovarian failure, resistant ovary syndrome and polycystic ovary
syndrome: G. s. CONWAY, E. CONWAY, c. WALKER, w. HOPPNER,
J. GROMOLL AND M. SIMONI

101 Type I multiple endocrine neoplasia (MENI): contribution of
genetic analysis to the screening and follow-up of a large French
kindred: c. WATERLOT, N. PORCHET, C. BAUTERS, M. DECOULX,
J. L. WEMEAU, C. PROVE, P. M. DEGAND, J. P. AÜBERT, C. CORTET
AND D. DEWAILLY

109 Incidentally discovered pituitary lesions: high freqency of
macroadenomas and hormone-secreting adenomas — results
of a prospective study: J. FELDKAMP, R. SANTEN, E. HARMS,
A. AULICH, U. MODDER AND W. A. SCHERBAUM

115 Association of the large multifunctional proteasome (LMP2)
gene with Graves' disease is a result of linkage disequilibrium
with the HLAhaplotype DRB1*0304-DQB1*02-DQA1*0501:
J. M. HEWARD, A. ALLAHABADIA, M. C. SHEPPARD, A. H. BARNETT,
J. A. FRANKLYN AND S. C. L. GOUGH

119 Macroprolactinaemia: validation and application of the
polyethylene glycol precipitation test and clinical characterisation
of the condition: A. o. OLUKOGA AND J. w. KANE

Case report
127 Ovarian responses to hCG stimulation: insulin resistance/
hyperinsulinaemia vs. insulin deficiency: s. F. WITCHEL AND
S. ARSIANIAN

131 Letter to the Editors

137 Book review

137 Notices

_______________________________________


CLINICAL Endocrinology

Volume 51, Number 2, August 1999

Contents

Heview
139 Role ofFSH in the regulation of spermatogenesis: clinical
aspects: E. NIESCHLAG, M. SIMONI, J. GROMOLL AND
G. F. WEINBAUER

Commentary

147 Non-islet cell tumour hypoglycaemia: J. D. TEALE (see page 247)

149 The role of bilateral inferior petrosal sinus sampling in the
investigation ofACTH-dependent hypercortisolism:
A. B. ATKINSON (see page 255)


151 The short Synacthen test: is less best?: P. M. STEWART AND
P. M. s. CLARK (see page 153)

Original papers

153 Reproducibility of the cortisol response to stimulation with the
low dose (I ug) ofACTH: Y. J. PARK, K. s. PARK, J. H. KIM,
c. s. SHIN, s. Y. KIM AND H. K. LEE (see commentary page 151 )

159 Comparison of six months therapy with octreotide versus
lanreotide in acromegalic patients: a retrospective study:
P. RAZZORE, A. COLAO, R. BALDELLI, D. GAIA, P. MARZULLO,
E. FERRETTI, D. FERONE, M. L. JAFFRAIN-REA, G. TAMBURRANO,
G. LOMBARDI, F. CAMANNI AND E. CICCARELLI

165 A novel mutation in the TPO gene in goitrous hypothyroid
patients with iodide organification defect: c. L. s. SANTOS,
H. BIKKER, K. G. M. REGO, A. C. NASCIMENTO, M. TABASCIA,
J. J. M. DE VIJLDER AND G. MEDEIROS-NETO

173 Growth hormone (GH) replacement therapy reduces serum
sialic acd concentrations in adults with GH-deficiency: a
double-blind placebo-controlled study: E. R. CHRIST,
M. H. CUMMINGS, P. J. LUMB, M. A. CROOK, P. H. SONKSEN AND
D. L. RUSSELL-JONES

181 Classical pituitary apoplexy: clinical features, management and
outcome: H. s. RANDEVA, J. SCHOEBEL, J. BYRNE, M. ESIRI,
C. B. T. ADAMS AND J. A. H. WASS

189 Ontogeny of serum leptin concentrations in the human:
M. GEARY, R. HERSCHKOVITZ, P. J. PRINGLE, C. H. RODECK AND
P. C. HINDMARSH

193 The continuous 7-hour intravenous dexamethasone suppression
test in the differential diagnosis ofACTH-dependent Gushing's
syndrome: D. P. M. VAN DEN BOGAERT, w. w. DE HERDER,
F. H. DE JONG, P. BIEMOND, A. J. VAN DER LELY AND
S. W. J. LAMBERTS


199 Leptin serum concentrations in healthy neonates within the first
week of life: relation to insulin and growth hormone levels,
skinfold thickness, body mass index and weight: c. SCHUBRING,
T. SIEBLER, J. KRATZSCH, P. ENGLARO, W. F. BLUM, K. TRIEP AND
W. KIESS

205 Sleep deprivation effects on the activity of the hypothalamic-
pituitary—adrenal and growth axes: potential clinical implications:
A. N. VGONTZAS, Ci. MASTORAKOS, E. 0. BIXLER, A. KALES,
P. W. GOLD AND G. P. CHROUSOS

217 Vitamin D insufficiency increases bone turnover markers and
enhances bone loss at the hip in patients with established vertebral
osteoporosis: o. SAHOTA, T. MASLJD, p. SAN AND D. J. HOSKING

223 Syndrome of body fat redistribution in HIV-1 -infected patients:
relationships to cortisol and catecholamines: E. RENARD, J. FABRE,
K PARIS, J. REYNES AND J. BRINGHR

231 The effects of metformin on insulin resistance and ovarian
steroidogenesis in women with polycystic ovary syndrome:
K. UNLUHIZARCI, F. KELE^TIMUR, F. BAYRAM, Y.SAHIN AND
A. TUTLJS

237 Neuromusclilar symptoms and dysfunction in subclinical
hypothyroid patients: beneficial effect of L-T4 replacement
therapy: F. MONZANI, N. CARACCIO, p. DEL GUERRA, A. CASOLARO
AND E. FERRANNINI

243 Association of molecular variants of luteinizing hormone with
menstrual disorders: L. N. RAMANUJAM, w. x. LIAO, A. c. ROY,
A. LOGANATH, H. H. GOH AND S. C. NG

Case report

247 Hypoglycaemia associated with the production of insulin-like
growth factor II and insulin-like growth factor binding protein
6 by a haemangiopericytoma: K. HOEKMAN, J. VAN DOORN,
T. GI.OUDEMANS, J. A. MAASSEN, A. G. P. SCHULLER AND
H. M. PINEDO (see commentary page 147)

255 Letters to the Editors (see commentary page 149)

262 Book review


_______________________________________



Clinical Endocrinology

Volume 51, Number 3, September 1999

Contents

Editorial

263 Role of postoperative radiotherapy in the treatment of pituitary
tumours: A. B. GROSSMAN AND P. KENDALL-TAYLOR

Review
265 Pituitary adenoma radiotherapy -when and how?: P.N.PLOWMAN
Commentary

273 Toward better treatment of congenital adrenal hyperplasia:
p. w. SPEISER (see page 285)


Rapid communication

275 A comparison of lanreotide and octreotide LAR for treatment
of acromegaly: H. E. TURNER, A. VADIVALE, J. KEENAN AND
J. A. H. WASS

Original papers

281 Audit of selected patients with non-functioning pituitary adenomas
treated without irradiation - a follow-up study: H. E. TURNER,
I. M. STRATTON, J. V. BYRNE, C. B. T. ADAMS AND J. A. H. WASS


285 Effect of carbenoxolone on the plasma renin activity and
hypothalamic-pituitary-adrenal axis in congenital adrenal
hyperplasia due to 21-hydroxylase deficiency: i. IRONY AND
G. B. CUTLER (see commentary page 273)

293 Increased pressor response to noradrenaline in pituitary dependent
Cushing's syndrome: A. P. HEANEY, S. J. HUNTER, B. SHERIDAN
AND A. B. ATKINSON


301 The relationship among circulating insulin-like growth factor
components, biochemical markers of bone turnover and bone
mineral density in postmenopausal women under the age of 60:
J. G. KIM, C. S. SHIN, Y. M. CHOI, S. Y. MOON, S. Y. KIM AND
J. Y. LEE

309 Growth hormone (GH) status is an independent determinant of
serum levels ofcholesterol and triglycerides in healthy adults:
N. VAHL, I. KLAUSEN, J. S. CHRISTIANSEN AND J. 0. L. J0RGENSEN


317 pl6 (INK4^, MTS-1 ) gene polymorphism and methylation status
in human pituitary tumours: M. L. JAFFRAIN-REA, E. FERRETTI,
E. TONIATO, K. CANNITA, A. SANTORO, D. Dl STEFANO, E. RICEVUTO,
M. MARODER, G. TAMBURRANO, G. CANTORE, A. GULINO AND
S. MARTINOTTI

327 Splanchnic exchange of insulin-like growth factor binding
protein-1 (IGFBP-I), IGF-I and acid-labile subinit (ALS) during
normo- and hyper-insulinaemia in healthy subjects:
E. FERNQVIST-FORBES, K. EKBERG, B. F. LINDGREN AND K. BRISMAR

333 The quality of life of adults with growth hormone deficiency:
comparison with diabetic patients and control subjects:
M. WALLYMAHMED, P. FOY AND I. A. MACFARLANE


339 Serum IGF-I and IGFBP-3 concentrations do not accurately
predict growth hormone deficiency in children with brain tumours:
S. A. WEINZIMER, S. A. HOMAN, R. J. FERRY AND T. MOSHANG

347 Lipid profile, glucose tolerance and insulin sensitivity after more
than four years of growth hormone therapy in non-growth
hormone deficient adolescents: P. BAREILLE, C. AZCONA,
D. R. MATTHEWS, G. S. CONWAY AND R. STANHOPE

355 Mutations in intron 3 of GH-1 gene associated with isolated GH
deficiency type II in three Japanese families: T. KAMIJO,
Y. HAYASHI, A. SHIMATSU, E. KINOSHITA, M. YOSHIMOTO,
M. OGAWA AND H. SEO

361 The prevalence of thyroid dysfunction in a population with
borderline iodine deficiency: N. KNUDSEN, T. J0RGENSEN,
S. RASMUSSEN, E. CHRISTIANSEN AND H. PERRILD

369 Hexarelin as a test of pituitary reserve in patients with pituitary
disease: M. KORBONITS, G. KALTSAS, L. A. PERRY, A. B. GROSSMAN,
J. P. MONSON, G. M. BESSER AND P. J. TRAINER

Case report

377 Pituitary apoplexy following metastasis of bronchogenic
adenocarcinoma to a prolactinoma: F. w. F. H ANNA,
O. M. WILLIAMS, J. S. DAVIES, T. DAWSON, J. NEAL AND
M. F. SCANLON

383 Book reviews
Author's Declaration


 

_______________________________________